Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours

Abstract

KILLED Corynebacterium parvum has been effective when administered into tumours or when included as a subcutaneous inoculum containing tumour cells (the subcutaneous site, unlike the intradermal site1, facilitates early tumour cell dissemination)2–4. After tumour rejection, the augmented host resistance prevented progressive growth of potentially lethal metastases present at the time of therapy5. In addition, animals rejecting tumours formed from primary grafts of tumour cells admixed with killed C. parvum (compared with those rejecting tumours after intratumour therapy with C. parvum) exhibited an augmented tumour-specific protection against inoculation of large challenge cell doses6. Whitmire and Huebner7 reported a significant decrease in incidence of 3-methyl-cholanthrene-induced malignancies in C57BL/Cum and BALB/c Cv mice after preimmunisation with formalin-killed wild-type virus and Rauscher leukaemia virus vaccines administered with Freund's complete adjuvant. We have now found a considerable decrease in the incidence of spontaneous tumours in the high-incidence strain of DBA/2 mice after rejection of tumours formed from subcutaneous transplants of syngeneic mammary adenocarcinoma cells admixed with killed C. parvum.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gross, L., Cancer Res., 3, 326–336 (1943).

    Google Scholar 

  2. Likhite, V. V., and Halpern, B. N., Int. J. Cancer, 12, 699–704 (1973).

    Article  CAS  PubMed  Google Scholar 

  3. Likhite, V. V., and Halpern, B. N., Cancer Res., 34, 341–344 (1974).

    CAS  PubMed  Google Scholar 

  4. Paslin, D., Dimitrov, N. V., and Heaton, C., J. natn. Cancer Inst., 52, 571–573 (1974).

    Article  CAS  Google Scholar 

  5. Likhite, V. V., Int. J. Cancer, 14, 684–690 (1974).

    Article  CAS  PubMed  Google Scholar 

  6. Likhite, V. V., in Corynebacterium parvum: Applications in Experimental and Clinical Oncology (Plenum, New York, in the press).

  7. Whitmire, C. E., and Huebner, R. J., Science, 177, 60–63 (1972).

    Article  ADS  CAS  PubMed  Google Scholar 

  8. Likhite, V. V., Cancer Res., 34, 2790–2794 (1974).

    CAS  PubMed  Google Scholar 

  9. Glynn, J. P., Bianco, A. R., and Goldin, A., Cancer Res., 24, 502–508 (1964).

    CAS  PubMed  Google Scholar 

  10. Sachs, L., J. natn. Cancer Inst., 29, 759–764 (1962).

    CAS  Google Scholar 

  11. Johnson, N., and Sjögren, H. O., J. exp. Med., 122, 403–421 (1965).

    Article  Google Scholar 

  12. Lavrin, D. H., Blair, P. B., and Weiss, D. W., Cancer Res., 26, 929–934 (1966).

    CAS  PubMed  Google Scholar 

  13. Klein, G., Sjögren, H., and Klein, E., Cancer Res., 22, 955–961 (1962).

    CAS  PubMed  Google Scholar 

  14. Klein, E., and Klein, G., J. natn. Cancer Inst., 32, 547–568 (1964).

    CAS  Google Scholar 

  15. Klein, G., Fedn Proc., 28, 1739 (1969).

    CAS  Google Scholar 

  16. Holmes, E. C., Kahan, B. D., and Morton, D. L., Cancer, 25, 373–379 (1970).

    Article  CAS  PubMed  Google Scholar 

  17. Kronman, B. S., et al., Science, 168, 257–259 (1970).

    Article  ADS  CAS  PubMed  Google Scholar 

  18. Eilber, F. R., Holmes, D., and Morton, D. L., J. natn. Can. Inst., 46, 803–808 (1971).

    CAS  Google Scholar 

  19. Halpern, B., et al., in CIBA Foundation Symp.: Immunopotentiation, 217–234 (Elsevier, North Holland, Amsterdam, 1973).

    Google Scholar 

  20. Howard, H. G., Scott, M. T., and Christie, G. H., in CIBA Foundation Symp.: Immunopotentiation, 101–120 (Elsevier, North Holland, Amsterdam, 1973).

    Google Scholar 

  21. Likhite, V. V., J. Immun., 114, 1736–1742 (1975).

    CAS  PubMed  Google Scholar 

  22. Frost, P., and Lance, E. M., in CIBA Foundation Symp.: Immunopotentiation, 29–38 (Elsevier, North Holland, Amsterdam, 1973).

    Google Scholar 

  23. Biozzi, G., Howard, J. G., Mouton, D., and Stiffel, C., Transplantation, 3, 170–177 (1965).

    Article  CAS  PubMed  Google Scholar 

  24. Lamensans, A. C., et al., Revue fr. Etud. clin Biol., 13, 773–779 (1968).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LIKHITE, V. Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours. Nature 259, 397–399 (1976). https://doi.org/10.1038/259397a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/259397a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing